UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030714 |
|---|---|
| Receipt number | R000035065 |
| Scientific Title | Effect of acupuncture on major depressive disorder and bipolar disorder |
| Date of disclosure of the study information | 2018/01/06 |
| Last modified on | 2021/11/04 11:41:07 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of acupuncture on major depressive disorder and bipolar disorder
Acronym
Effect of acupuncture on major depressive disorder and bipolar disorder
Scientific Title
Effect of acupuncture on major depressive disorder and bipolar disorder
Scientific Title:Acronym
Effect of acupuncture on major depressive disorder and bipolar disorder
Region
| Japan |
Condition
Condition
Major Depressive Disorder
Bipolar Disorder
Classification by specialty
| Psychiatry |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to examine the effect of acupuncture treatment on depression and bipolar disorder.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Himorogi self-rating depression scale
Key secondary outcomes
Himorogi self-rating anxiety scale
Somatic Symptom Scale-8
Visual Analogue Scale
SF8 Health Survey
Salivary cortisol
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
Acupuncture
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 80 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1.Those aged 18 or over with MDD(by DSM-5)
2.Those aged 18 or over with BD(by DSM-5)
Key exclusion criteria
1.Those with convulsive disorders such as schizoph.
2.Those with depression or depressive state caused by organic brain damages.
3.Those with severe disorders in liver, kidney, blood or circulation.
4.Those with malignancy or its previous history.
5.Those pregnant, nursing, or who may become pregnant.
6.Those with heavy suicidal tendency, previous history of suicidal ideation, or suicide attempt.
7.Those with personality disorder, mental retardation or intractable depression at a physician's discretion.
8.Those with substance dependence or drug abuse (excluding disorders related to nicotine).
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Tomomi |
| Middle name | |
| Last name | Sakai |
Organization
Tokyo Ariake University of Medical and Health Science
Division name
Department of Acupuncture and Moxibustion
Zip code
135-0063
Address
2-9-1 Ariake Koto-ku, Tokyo 135-0063 Japan
TEL
+08-3-6703-7014
matsuuray@tau.ac.jp
Public contact
Name of contact person
| 1st name | Yuto |
| Middle name | |
| Last name | Matsuura |
Organization
Graduate School of Tokyo Ariake University of Medical and Health Sciences
Division name
Doctor's Program of Health Sciences
Zip code
135-0063
Address
2-9-1 Ariake Koto-ku, Tokyo 135-0063 Japan
TEL
+08-3-6703-7014
Homepage URL
himorogi.hari@gmail.com
Sponsor or person
Institute
Tokyo Ariake University of Medical and Health Science
Institute
Department
Personal name
Funding Source
Organization
Tokyo Ariake University of Medical and Health Science
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Himorogi Psychiatric Institute
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tokyo Ariake University of Medical and Health Science
Address
2-9-1 Ariake Koto-ku, Tokyo 135-0063 Japan
Tel
+08-3-6703-7000
akiyama@tau.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
市ヶ谷ひもろぎクリニック（東京都）
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 01 | Month | 06 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 03 | Month | 01 | Day |
Date of IRB
| 2017 | Year | 04 | Month | 19 | Day |
Anticipated trial start date
| 2017 | Year | 05 | Month | 01 | Day |
Last follow-up date
| 2022 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2018 | Year | 01 | Month | 06 | Day |
Last modified on
| 2021 | Year | 11 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035065
